Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Addiction Recovery Institute (ARI) is a private outpatient healthcare provider specializing in the treatment of opioid use disorder and other substance use disorders. Based in Rhode Island with locations in Pawtucket and Warwick, the institute provides comprehensive medication-assisted treatment (MAT) utilizing methadone and buprenorphine, integrated with individual and group counseling. ARI is a SAMHSA-certified Opioid Treatment Program (OTP) and is accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF). The organization is dedicated to a whole-person approach to recovery, offering evidence-based therapies such as cognitive-behavioral therapy (CBT) and motivational interviewing to support long-term sobriety and improved quality of life for its patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Addiction Recovery Institute.